![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/ADVENZYMES.png)
Share the post "Advanced Enzyme Technologies L’s Q3 2024-25 Latest News: Revenue Grows by 5.08% YoY"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 5.08 % in the past year, substantial increase in net sales/revenue by 15.75 %. 🔹 Income over the Year and quarter: There has been decline in other income over the past year which is -46.62 %, Marginal decrease of -20.1% in other income during this quarter. 🔹 Profit over the Year and quarter: Challenges in sustaining profitability for Advanced Enzyme Technologies L. Profit dropped by -8.53 % Year to Year, Advanced Enzyme Technologies L’s profitability increased by 16.42 % in this quarter. 🔹 EPS over the Year and quarter: EPS declined by -10.16 % Year to Year. EPS increased by 14.29 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 160.935 Cr | Rs. 146.095 Cr | Rs. 169.112 Cr | + 15.75 % | + 5.08 % |
| Expenses | Rs. 107.17 Cr | Rs. 103.68 Cr | Rs. 113.86 Cr | + 9.82 % | + 6.24 % |
| Operating Profit | Rs. 53.77 Cr | Rs. 42.42 Cr | Rs. 55.25 Cr | + 30.25 % | + 2.75 % |
| OPM % | 33.41 % | 29.04 % | 32.67 % | + 3.63 % | -0.74 % |
| Other Income | Rs. 14.396 Cr | Rs. 9.618 Cr | Rs. 7.685 Cr | -20.1 % | -46.62 % |
| Interest | Rs. 0.68 Cr | Rs. 0.93 Cr | Rs. 0.94 Cr | + 1.08 % | + 38.24 % |
| Depreciation | Rs. 8.6 Cr | Rs. 8.9 Cr | Rs. 8.97 Cr | + 0.79 % | + 4.3 % |
| Profit before tax | Rs. 58.89 Cr | Rs. 42.21 Cr | Rs. 53.03 Cr | + 25.63 % | -9.95 % |
| Tax % | 27.81 % | 20.89 % | 26.68 % | + 5.79 % | -1.13 % |
| Net Profit | Rs. 42.5 Cr | Rs. 33.39 Cr | Rs. 38.88 Cr | + 16.44 % | -8.52 % |
| EPS in Rs | Rs. 3.74 | Rs. 2.93 | Rs. 3.36 | + 14.68 % | -10.16 % |
Today, we’re looking at Advanced Enzyme Technologies L’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 5.08 %. However, it did see a marginal increase of 15.75 % from the previous quarter. Expenses ticked up slightly by 9.82 % quarter-on-quarter, aligning with the annual rise of 6.24 %. Operating profit, while up 2.75 % compared to last year, faced a quarter-on-quarter increase of 30.25 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -0.74 %, but an expansion of 3.63 % sequentially. Other income fell by -20.1 % compared to the last quarter, despite an annual decline of -46.62 %. Interest expenses surged remarkably by 1.08 % from the previous quarter, yet the year-over-year increase remains at a moderate 38.24 %. Depreciation costs climbed by 0.79 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 4.3 %. Profit before tax declined annually by -9.95 % but saw an increase from the preceding quarter by 25.63 %.
Tax expenses as a percentage of profits decreased slightly by -1.13 % compared to last year, with a more notable quarter-on-quarter increase of 5.79 %. Net profit fell by -8.52 % year-on-year but experienced a 16.44 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -10.16 % but a quarterly rise of 14.68 %. In summary, Advanced Enzyme Technologies L’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 160.935 Cr | Rs. 146.095 Cr | Rs. 169.112 Cr | + 15.75 % | + 5.08 % |
| Expenses | Rs. 107.17 Cr | Rs. 103.68 Cr | Rs. 113.86 Cr | + 9.82 % | + 6.24 % |
| Operating Profit | Rs. 53.77 Cr | Rs. 42.42 Cr | Rs. 55.25 Cr | + 30.25 % | + 2.75 % |
| Net Profit | Rs. 42.5 Cr | Rs. 33.39 Cr | Rs. 38.88 Cr | + 16.44 % | -8.52 % |
| EPS in Rs | Rs. 3.74 | Rs. 2.93 | Rs. 3.36 | + 14.68 % | -10.16 % |
In reviewing Advanced Enzyme Technologies L’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 5.08 % year-on-year growth, however, there was a minor increase of 15.75 % from the previous quarter. Expenses rose by 6.24 % compared to the previous year, with a 9.82 % increase quarter-on-quarter. Operating Profit surged by 2.75 % annually, and saw a 30.25 % increase from the last quarter.
Net Profit showed yearly decrease of -8.52 %, and experienced a 16.44 % increase from the previous quarter. Earnings Per Share (EPS) fell by -10.16 % annually, however rose by 14.68 % compared to the last quarter. In essence, while Advanced Enzyme Technologies L faces strong annual decline indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/COASTCORP.png)
